tiprankstipranks
Trending News
More News >
American Oriental Bioengineering Inc (AOBI)
OTHER OTC:AOBI
US Market
Advertisement

American Oriental Bioengineering Inc

Compare
10 Followers

AOBI Stock Chart & Stats

$1.88
$0.00(0.00%)
At close: 4:00 PM EDT
$1.88
$0.00(0.00%)

AOBI FAQ

What was American Oriental Bioengineering Inc’s price range in the past 12 months?
American Oriental Bioengineering Inc lowest stock price was $1.01 and its highest was $2.75 in the past 12 months.
    What is American Oriental Bioengineering Inc’s market cap?
    American Oriental Bioengineering Inc’s market cap is $88.00.
      When is American Oriental Bioengineering Inc’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were American Oriental Bioengineering Inc’s earnings last quarter?
      Currently, no data Available
      Is American Oriental Bioengineering Inc overvalued?
      According to Wall Street analysts American Oriental Bioengineering Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does American Oriental Bioengineering Inc pay dividends?
        American Oriental Bioengineering Inc does not currently pay dividends.
        What is American Oriental Bioengineering Inc’s EPS estimate?
        American Oriental Bioengineering Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does American Oriental Bioengineering Inc have?
        American Oriental Bioengineering Inc has 73,000 shares outstanding.
          What happened to American Oriental Bioengineering Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of American Oriental Bioengineering Inc?
          Currently, no hedge funds are holding shares in AOBI

          Company Description

          American Oriental Bioengineering Inc

          American Oriental Bioengineering, Inc. engages in the development, manufacture, and commercialization of various pharmaceutical and healthcare products. The company primarily provides prescription pharmaceutical products, including Shuanghuanglian Lyophilized Injection Powder under the SHL brand for the treatment of flu symptoms, such as high fever, cough, and sore throat, as well as upper respiratory infections, mild pneumonia, bronchitis, and tonsillitis; and Cease Enuresis Soft Gel under the CE Gel brand to alleviate bedwetting. It also offers over-the-counter pharmaceutical products comprising Cease Enuresis Patch for the treatment of bedwetting and incontinence; Jinji Capsule for the treatment of endometritis, annexitis, and pelvic inflammations; Jinji Yimucao for the treatment of premenstrual syndrome (PMS) and other PMS and menopause-related symptoms; and Boke Nasal Spray for the treatment of sinus congestion from common cold, stuffy nose, chronic rhinitis, allergic rhinitis, and nasosinusitis. In addition, the company provides various nutraceutical products, such as soybean peptide based drinks, tablets, powder, and instant coffee. Further, it is involved in the wholesale and retail of pharmaceutical and nutraceutical products. The company sells its products directly and through distributors to hospitals, clinics, pharmacies, supermarkets, fitness centers, specialty nutraceutical stores, and other retail outlets in the People's Republic of China. American Oriental Bioengineering, Inc. is headquartered in Beijing, China.
          Similar Stocks
          Company
          Price & Change
          Follow
          Biodexa Pharmaceuticals
          Processa Pharmaceuticals
          GRI Bio
          Ocean Biomedical
          Onconetix

          Ownership Overview

          <0.01%100.00%
          Insiders
          Mutual Funds
          <0.01% Other Institutional Investors
          100.00% Public Companies and
          Individual Investors

          Options Prices

          Currently, No data available
          ---
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis